pharma

Allevi Joins Johnson&Johnson's JPOD Philadelphia Community

As new applications continue to be developed within the Allevi community, we feel the responsibility to join larger ecosystems that connect us with more engineers, scientists, and physicians that can benefit from the power of Allevi’s solutions. Our first successful relationship with a broader ecosystem has been with VWR. They continue to help us introduce our platform to accelerate science around the world. Adding geometry to biology is becoming a standard to be able to generate accurate representations of the body outside the body. 

At Allevi, we are now ready to begin to understand how to translate our communities’ scientific discoveries into the breakthroughs of tomorrow. To do this we realize that we need to co-create solutions with those at the front lines who are bringing new drugs to market, fighting diseases at the bedside, and producing novel solutions for the healthcare system.

Therefore, we are excited to join the Johnson & Johnson Innovation, JLABS JPOD @ Philadelphia community. We believe access to this ecosystem helps us connect with those who understand how Allevi’s applications can serve the healthcare industry. These interactions will guide our community today and in the future. Together we can target healthcare’s biggest needs by creating more accurate, predictable 3D biology models.

As we continue to collaborate with the Johnson & Johnson Innovation community, we will look forward to receiving mentorship, brainstorming with great minds in the industry, and continuing to grow Allevi. It takes a village to raise a company and we are happy to have the JLABS village help us reach new heights.

Cosmetic Animal Testing is on its Way Out

allevi ban cosmetic animal testing 3d bioprint instead.jpg

The fight to ban animal testing recently scored a major victory when California became the first US state to pass a bill that would ban testing cosmetics on animals.

Companies conduct animal tests to determine the safety of new formulas used in cosmetic products. These tests include skin and eye irritation tests to study allergic reactions and “lethal-dose” testing to determine ingredient toxicity.

But these tests have scientific limitations because humans and animals react differently to certain chemicals. Therefore these tests, that are meant to study the safety of cosmetics before they touch human skin, aren’t even relevant.

Here at Allevi, we believe in the future of personalized cosmetic testing. Our 3D bioprinters allow researchers to customize every aspect of their study - including tissue shape, size, geometry and cell line. Imagine a world where drugs and cosmetics are no longer cruelly tested on animals, but tested on patches of human tissue. But not just any human’s tissue but YOURS because you are different from a rabbit and different from a monkey and even different from your fellow human.

We applaud California for following in the EU, Norway, Israel and India’s footsteps. It’s time we replace these outdated methods; not only because they are cruel to animals but because they are ineffective. Allevi is here to usher in a new era for a cruelty free and scientifically relevant future.

Meet Allevi 3: The bioprinter for every application.

Allevi 3 bioprinter triple extruder bioprinter

Have you noticed? Exciting things are happening in the fields of tissue engineering and regenerative medicine. Since our humble beginnings, the Allevi community has grown to labs in all corners of the globe and includes the world’s best scientists and pharmaceutical innovators. And your work is having an impact.

With every new #AlleviAuthor paper that gets published, our incredible community wows us with yet another mind-blowing application. Whether you are creating personalized bone grafts, printing tumor models for better drug testing, or studying the dynamics of the vasculature system - we provided you a tool and you have amazed us with what you have accomplished with it.

Today, we’re excited to announce the newest addition to the Allevi family of 3D bioprinters that was inspired by your work - the Allevi 3. The Allevi 3 is easy to use, extremely versatile, and yet still incredibly powerful. Check out the bioprinter that can bring your work to life. What will you build?

Bioprinting offers hope of new treatment paths for cancer patients

Univ of Waikato 3d bioprinter bioprint allevi .jpg

Our amazing users at The University of Waikato will use their Allevi 2 to research new treatment paths for cancer patients that could eventually lead to cancer tumors being treated outside patients' bodies.

We are constantly inspired by this amazing community of scientists who are changing the way we design, heal and build with life. And we're here to support them along the way! Read on to learn more about this incredible research.

Allevi Author: 3D bioprinting drug delivery systems

abo akademi allevi bioprinting allevi 2.jpg

Time for another #AlleviAuthor - Researchers from Abo Akademi, University of Helsinki and University of Turku use the Allevi 2 to 3D bioprint drug delivery systems.

Their paper studies the printability of PDMS to manufacture drug containing structures of different pore sizes and different drug loadings. The 3d bioprinted structures contained prednisolone as the model drug.

abo akademi allevi drug delivery.jpg

The work showed that by altering the surface area/volume ratio it was possible to print structures with differences in the release rate. The fact that the 3d bioprinting was performed at room temperature makes this an interesting alternative for manufacturing controlled release device with temperature susceptible drugs.

Imagine being able to 3d print the perfect drug for YOUR biology - to be able to control geometry, custom release rates, and multi-drug composition. This paper explores the future of truly personalized drug delivery.

Download the full paper here.